Market pulse › Organon
Organon
Today2 stories · 2 articles
Net tone▲ +50% today
Market checkSun Pharma +1.5%
Developing2 storylines
229 Sept
Broker call▲ bullishExpanding innovative portfolio may drive gains for Sun Pharma stockLerodalcibep licensing, US portfolio growth and tariff relief are cited as potential stock driversSun PharmaLerodalcibepPharma and healthcare
Funding and debt● mixedSun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: ReportSun Pharma plans a ₹10,000 crore bond sale to refinance its Organon dealSun PharmaPharma and healthcareBond yields